These will be crucial for elucidating the molecular mechanisms by which the CSPG4P12 rs8040855 variant contributes to esophageal cancer pathogenesis and could reveal novel targets for therapeutic intervention. This evidence concerns the gene CSPG4P12 and esophageal cancer.